Literature DB >> 29302778

A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism.

Bart Swinnen1,2,3, Andre Bento-Abreu1,2, Tania F Gendron4, Steven Boeynaems1,2, Elke Bogaert1,2, Rik Nuyts1,2, Mieke Timmers1,2, Wendy Scheveneels1,2, Nicole Hersmus1,2, Jiou Wang5, Sarah Mizielinska6,7, Adrian M Isaacs6,8, Leonard Petrucelli4, Robin Lemmens1,2,3, Philip Van Damme1,2,3, Ludo Van Den Bosch9,10, Wim Robberecht11,12,13.   

Abstract

The exact mechanism underlying amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) associated with the GGGGCC repeat expansion in C9orf72 is still unclear. Two gain-of-function mechanisms are possible: repeat RNA toxicity and dipeptide repeat protein (DPR) toxicity. We here dissected both possibilities using a zebrafish model for ALS. Expression of two DPRs, glycine-arginine and proline-arginine, induced a motor axonopathy. Similarly, expanded sense and antisense repeat RNA also induced a motor axonopathy and formed mainly cytoplasmic RNA foci. However, DPRs were not detected in these conditions. Moreover, stop codon-interrupted repeat RNA still induced a motor axonopathy and a synergistic role of low levels of DPRs was excluded. Altogether, these results show that repeat RNA toxicity is independent of DPR formation. This RNA toxicity, but not the DPR toxicity, was attenuated by the RNA-binding protein Pur-alpha and the autophagy-related protein p62. Our findings demonstrate that RNA toxicity, independent of DPR toxicity, can contribute to the pathogenesis of C9orf72-associated ALS/FTD.

Entities:  

Keywords:  ALS; C9orf72; DPR; Pur-alpha; RNA toxicity; Zebrafish; p62

Mesh:

Substances:

Year:  2018        PMID: 29302778     DOI: 10.1007/s00401-017-1796-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  42 in total

1.  Repeat-associated non-ATG (RAN) translation.

Authors:  John Douglas Cleary; Amrutha Pattamatta; Laura P W Ranum
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

2.  Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS/FTD.

Authors:  Hana M Odeh; James Shorter
Journal:  Emerg Top Life Sci       Date:  2020-12-11

Review 3.  RNA-mediated toxicity in C9orf72 ALS and FTD.

Authors:  Zachary T McEachin; Janani Parameswaran; Nisha Raj; Gary J Bassell; Jie Jiang
Journal:  Neurobiol Dis       Date:  2020-08-21       Impact factor: 5.996

4.  A synthetic Pur-based peptide binds and alters G-quadruplex secondary structure present in the expanded RNA repeat of C9orf72 ALS/FTD.

Authors:  Margaret J Wortman; Ayuna V Dagdanova; Andrea M Clark; Earl W Godfrey; Steven M Pascal; Edward M Johnson; Dianne C Daniel
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-02-06       Impact factor: 4.739

5.  Expression of C9orf72-related dipeptides impairs motor function in a vertebrate model.

Authors:  Amrutha Swaminathan; Marilou Bouffard; Meijiang Liao; Sarah Ryan; Janis Bennion Callister; Stuart M Pickering-Brown; Gary Alan Barclay Armstrong; Pierre Drapeau
Journal:  Hum Mol Genet       Date:  2018-05-15       Impact factor: 6.150

Review 6.  Neurodegenerative diseases have genetic hallmarks of autoinflammatory disease.

Authors:  Robert I Richards; Sarah A Robertson; Daniel L Kastner
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

7.  C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation.

Authors:  Nausicaa V Licata; Riccardo Cristofani; Sally Salomonsson; Katherine M Wilson; Liam Kempthorne; Deniz Vaizoglu; Vito G D'Agostino; Daniele Pollini; Rosa Loffredo; Michael Pancher; Valentina Adami; Paola Bellosta; Antonia Ratti; Gabriella Viero; Alessandro Quattrone; Adrian M Isaacs; Angelo Poletti; Alessandro Provenzani
Journal:  EMBO J       Date:  2021-11-18       Impact factor: 11.598

Review 8.  Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Authors:  Zongbing Hao; Rui Wang; Haigang Ren; Guanghui Wang
Journal:  Neurosci Bull       Date:  2020-08-29       Impact factor: 5.203

Review 9.  C9orf72-mediated ALS and FTD: multiple pathways to disease.

Authors:  Rubika Balendra; Adrian M Isaacs
Journal:  Nat Rev Neurol       Date:  2018-09       Impact factor: 42.937

10.  Reduced C9orf72 function leads to defective synaptic vesicle release and neuromuscular dysfunction in zebrafish.

Authors:  Zoé Butti; Yingzhou Edward Pan; Jean Giacomotto; Shunmoogum A Patten
Journal:  Commun Biol       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.